9 December 2018 - A disruptive market of $410 billion until 2023, changes dramatically with the entrance of small and medium size players, many of them rising up from the startup community. 

Software plays a big part in this shift as a differentiator in medical devices as well as the manufacturing of portable devices used by the end user. Devices like blood glucose monitors, heart rate monitors, pulse oximeters and some others less widely used, like Alzheimer test applications and pacemakers with embedded WiFi capabilities may be in an everyday frequency by companies that some years ago were unknown to the wide population. 

A lot of people may have heard of Abbott Laboratories, Johnson & Johnson and Philips, but how many know Neurometrix and Sonova. In addition, companies coming from the lifestyle market like Apple and Fitbit try to gain a big portion of the market, using design and a bucket full of attractive features.

Read Forbes article